Entecavir Anhydrous
2 NDCs across 1 manufacturer|2 Generic,0 Brand
Entecavir Anhydrous is used to treat chronic hepatitis b, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Entecavir Anhydrous is available as 2 NDCs from 1 manufacturer (2 generic, 0 brand), with NADAC prices from $0.21 to $0.37 per EA — a 71% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
2G / 0B
Manufacturers
1
competing in market
Price Spread
$0.21 – $0.37
per EA
7d Activity
avg +2.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing ENTECAVIR ANHYDROUS
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ENTECAVIR 1 MG TABLET | $0.3658 per EA | +3.92% |
ENTECAVIR 0.5 MG TABLET | $0.2134 per EA | +0.14% |
Frequently Asked Questions
What is Entecavir Anhydrous used to treat?
Entecavir Anhydrous is used to treat chronic hepatitis b, per the National Library of Medicine's MED-RT classification.
How many Entecavir Anhydrous products are on the market?
The Entecavir Anhydrous drug market contains 2 NDCs from 1 manufacturer — 2 generic and 0 brand products.
What is the price range for Entecavir Anhydrous?
NADAC reference prices for Entecavir Anhydrous range from $0.2134 to $0.3658 per EA — a 71% difference between cheapest and most expensive.
Which manufacturers make Entecavir Anhydrous?
1 manufacturer lists Entecavir Anhydrous in NADAC. Ranked by number of NDCs, the largest are Cameron Pharmaceuticals (2).
How has the price of Entecavir Anhydrous changed recently?
Over the past 7 days, 2 Entecavir Anhydrous NDCs rose and 0 fell, with a market-wide average change of +2.0%.